Minze Health, a Antwerp, Belgium-based company which specializes in digital health solutions for urology, raised US$ 5.3M in funding.
The round was led by its existing investors White Fund, Capricorn Digital Growth Fund, and the Flemish investment company PMV, with participation from imec.istart future fund.
The company intends to use the funds to further develop and bring to market Prescription Digital Therapeutics (PDTs) for patients with urinary dysfunctions with an initial focus on Germany and France, as well as to drive US market entry with at home diagnostic solutions.
Led by Wilfried Woesthuis (CEO), Gilles Tas (founder, COO), Jiri Vermeulen (founder, CPO), Minze Health is a digital health company focused on transforming the diagnosis, monitoring, and treatment of urinary conditions through innovative technologies. Specializing in urology, it develops solutions such as remote monitoring systems and Prescription Digital Therapeutics (PDTs) that empower patients and provide healthcare professionals with continuous, data-driven insights for personalized care.
Their flagship products, including Homeflow, enable effective management of conditions like benign prostatic hyperplasia (BPH) from the comfort of patients’ homes.
To implement its ambitious plans in the US, Minze Health announced the appointment of Drew Moore as Vice President Marketing and Sales.
FinSMEs
17/10/2024